Gimv NV
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GIMB.BR | 82K.F | GCMG | PEHN.SW | GAM | 8518.T | |
|---|---|---|---|---|---|---|
| Market cap | 1.81B | 213.77M | 796.48M | 141.71M | 1.54B | 3.66B |
| P/E (TTM) | 8.2 | — | 25.1 | — | 4.1 | — |
| Forward P/E | 42.9 | — | 12.1 | — | — | — |
| Price/book | 0.9 | 0.5 | 31.4 | 0.4 | 0.9 | 0.5 |
| Dividend yield | 3.94% | — | 3.68% | 1.69% | — | — |
| 1-year change | +7.96% | −17.73% | +11.46% | −2.48% | +3.29% | −42.92% |
| Today | −0.40% | 0.00% | +2.28% | 0.00% | +1.22% | 0.00% |
The closest companies by business and industry (Asset Management). Prices may be delayed up to 20 min.
Latest news
All GIMB.BR news ›Blue Point, Bencis Capital, Gimv drawn to equine healthcare; Inflexion to sell TICC business Celnor to Goldman Sachs Alternatives
A look at equine health, a sector which has drawn in firms such as Blue Point Capital, Gimv and Bencis Capital Partners; Inflexion agrees to sell a majority stake in Celnor Group to Goldman Sachs Alternatives. Blue Point, Bencis Capital,…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- pehub.com1
- privateequityinternational.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.